Pharma & Biotech
MaxCyte has confirmed that its CARMA Cell Therapies subsidiary will expand its phase I clinical trial of...
10.27 Tue 18 Aug 2020
Chaarat Gold says production on track at Kapan
Genel Energy showing resilience with low-cost production in Kurdistan
As Fevertree loses fizz, Skinny Tonic closes crowdfunding campaign early due to over demand
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.